About Centrum Diagnostyki i Mikrochirurgii Oka LENS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Shire
2
Apellis Pharmaceuticals, Inc.
1
Clearside Biomedical, Inc.
1
Samsung Bioepis Co., Ltd.
1
Xbrane Biopharma AB
1
Clinical Trials at Centrum Diagnostyki i Mikrochirurgii Oka LENS
During the past decade, Centrum Diagnostyki i Mikrochirurgii Oka LENS conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
2017-01-31
2018-12-10
Terminated
460
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
2017-03-27
2019-05-13
Terminated
219
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
2017-03-29
2018-10-01
Completed
753
A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)
2018-03-14
2019-12-09
Completed
705
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
2018-08-31
2023-01-30
Active, not recruiting
600
Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD
2019-04-19
2021-11-11
Completed
582
A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
2020-06-05
2023-07-18
Active, not recruiting
104
A Study to Investigate RO7200220 in Diabetic Macular Edema
2021-12-31
2025-05-31
Recruiting
400
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centrum Diagnostyki i Mikrochirurgii Oka LENS" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Shire" with 2 trials
sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "Samsung Bioepis Co., Ltd."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Diagnostyki i Mikrochirurgii Oka LENS"
#1 collaborator was "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centrum Diagnostyki i Mikrochirurgii Oka LENS
According to Clinical.Site data, the most researched conditions in "Centrum Diagnostyki i Mikrochirurgii Oka LENS" are
"Diabetic Macular Edema" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Age-Related Macular Degeneration" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Centrum Diagnostyki i Mikrochirurgii Oka LENS" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Diagnostyki i Mikrochirurgii Oka LENS
Most popular intervention types in "Centrum Diagnostyki i Mikrochirurgii Oka LENS" are "Drug" (8 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Ranibizumab" (3 trials), "Sham Procedure" (3 trials), "PVP-I 0.6%" (2 trials) and "RO7200220" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Diagnostyki i Mikrochirurgii Oka LENS
The vast majority of trials in "Centrum Diagnostyki i Mikrochirurgii Oka LENS" are
9 trials for "All" genders.
Clinical Trials Status at Centrum Diagnostyki i Mikrochirurgii Oka LENS
Currently, there are NaN active trials in "Centrum Diagnostyki i Mikrochirurgii Oka LENS".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Centrum Diagnostyki i Mikrochirurgii Oka LENS,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Diagnostyki i Mikrochirurgii Oka LENS, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".